ArticleArchives of insect biochemistry and physiology2026
Structure-Guided Design of an Interface-Derived Inhibitor Peptide Against Spodoptera frugiperda Digestive Trypsins.
Article in Archives of insect biochemistry and physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Spodoptera frugiperda is a major agricultural pest whose control requires safer and more sustainable alternatives. In this study, a rational in silico strategy was applied to design a bioinsecticidal peptide targeting digestive trypsin from S. frugiperda, using a functionally relevant interfacial region of the Dioscorin-trypsin complex as a structural template. Interface analysis allowed the identification of an 11-residue oligopeptide designated as PEP-11. Trypsin-peptide docking, pharmacophore profiling, and triplicate molecular dynamics simulations were performed to characterize its interaction with the trypsin model. Docking analysis revealed that PEP-11 binds through a cooperative network of polar and hydrophobic interactions, supporting favorable molecular recognition. Molecular dynamics analyses showed that the trypsin-PEP-11 complex remained stable throughout the 100 ns simulations, with limited structural deviations and flexibility mainly restricted to terminal and loop-exposed regions. In addition, the radius of gyration and solvent-accessible surface area remained stable, while intermolecular hydrogen bonds increased over time. MM/GBSA calculations yielded negative binding free energy values in all replicas, indicating energetically favorable binding. Overall, these results support the computational prioritization of PEP-11 as an interface-derived peptide candidate for future experimental evaluation, including enzymatic inhibition, selectivity, proteolytic stability, and bioactivity assays.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.